+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Surgical Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • PDF Icon

    Report

  • 330 Pages
  • December 2022
  • Region: Global
  • GlobalData
  • ID: 5714534
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher's Medical Devices sector report, “Surgical Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update' provides comprehensive information about the Surgical Heart Valves pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Surgical Heart Valves are used in cardiac surgeries to treat heart valves diseases where the affected heart valves are either replaced or repaired.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Surgical Heart Valves under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Surgical Heart Valves and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Surgical Heart Valves under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Surgical Heart Valves Overview

3 Products under Development
3.1 Surgical Heart Valves - Pipeline Products by Stage of Development
3.2 Surgical Heart Valves - Pipeline Products by Segment
3.3 Surgical Heart Valves - Pipeline Products by Territory
3.4 Surgical Heart Valves - Pipeline Products by Regulatory Path
3.5 Surgical Heart Valves - Pipeline Products by Estimated Approval Date
3.6 Surgical Heart Valves - Ongoing Clinical Trials

4 Surgical Heart Valves - Pipeline Products under Development by Companies
4.1 Surgical Heart Valves Companies - Pipeline Products by Stage of Development
4.2 Surgical Heart Valves - Pipeline Products by Stage of Development

5 Surgical Heart Valves Companies and Product Overview

6 Surgical Heart Valves- Recent Developments

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer

List of Tables
  • Surgical Heart Valves - Pipeline Products by Stage of Development
  • Surgical Heart Valves - Pipeline Products by Segment
  • Surgical Heart Valves - Pipeline Products by Territory
  • Surgical Heart Valves - Pipeline Products by Regulatory Path
  • Surgical Heart Valves - Pipeline Products by Estimated Approval Date
  • Surgical Heart Valves - Ongoing Clinical Trials
  • Surgical Heart Valves Companies - Pipeline Products by Stage of Development
  • Surgical Heart Valves - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Surgical Heart Valves - Pipeline Products by Stage of Development
  • Surgical Heart Valves - Pipeline Products by Segment
  • Surgical Heart Valves - Pipeline Products by Territory
  • Surgical Heart Valves - Pipeline Products by Regulatory Path
  • Surgical Heart Valves - Pipeline Products by Estimated Approval Date
  • Surgical Heart Valves - Ongoing Clinical Trials

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Affluent Medical SA
  • AGEless Biomedical Inc
  • Ample Medical Inc
  • Anchorvalve
  • Ancora Heart Inc
  • Anteris Technologies Ltd
  • Aptus LLC
  • Artivion Inc
  • Autus Valve Technologies Inc
  • BioLife4D Corp
  • Biostage Inc
  • Boston Children's Hospital
  • Boston Scientific Corp
  • Boston Scientific Scimed Inc
  • Cardiac Dimensions Inc
  • Cardiac Implants LLC
  • Cardiosolutions Inc
  • Celyad Oncology SA
  • Colibri Heart Valve LLC
  • Collagen Solutions Ltd
  • Collplant Biotechnologies Ltd
  • Colorado State University
  • Columbia University
  • ConKay Medical Systems Inc
  • CoreMedic AG
  • CorMatrix Cardiovascular Inc
  • CroiValve Ltd
  • CUBE SRL
  • Cytograft Tissue Engineering Inc (Inactive)
  • Daidalos Solutions BV
  • Department of Biomedical Engineering Columbia University
  • Edwards Lifesciences Corp
  • Emory University
  • Enlight Medical Technologies (Shanghai) Co Ltd
  • enVVeno Medical Corp
  • Florida International University
  • FluidForm Inc
  • Foldax Inc
  • Georgia Institute of Technology
  • Griffith University
  • Hangzhou DeJin Medtech Co Ltd
  • Harpoon Medical, Inc.
  • Hocor Cardiovascular Technologies, LLC
  • Innovator Lab Consultants India Pvt Ltd
  • Innovia LLC
  • InspireMD Inc
  • JC Medical, Inc.
  • Jiangsu Zhenyi Medical Technology Co Ltd
  • Jinshi Biotechnology (Changshu) Co Ltd
  • Kardium Inc
  • Kekai Life Sciences
  • Leman Cardiovascular SA
  • Lepu Medical Technology (Beijing) Co Ltd
  • Lifelet Medical Ltd
  • LuSeed Vascular
  • Mardil Medical, Inc.
  • Mayo Clinic
  • Medi-Line S.A.
  • Medtronic Plc
  • Meril Life Sciences Pvt Ltd
  • MiCardia Corp
  • Michigan Critical Care Consultants Inc
  • Micro Interventional Devices, Inc.
  • MicroPort Scientific Corp
  • Millipede LLC
  • Mitralign Inc
  • Mitre Medical Corp
  • MVRx, Inc.
  • National University of Singapore
  • NaviGate Cardiac Structures, Inc.
  • Neochord Inc
  • NewMed Medical Co Ltd
  • On-X Life Technologies Inc
  • OrbusNeich P&F
  • P+F Products + Features GmbH
  • Peca Labs Inc
  • Rambam Health Care Campus
  • Revivicor Inc
  • Shanghai Aoliu Medical Technology Co Ltd
  • Shanghai Hanyu Medical Technology Co Ltd
  • Shanghai Healing Medical Instruments Co Ltd
  • Shanghai Shenqi Medical Technology Co Ltd
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • St. Jude Medical LLC
  • Stellenbosch University
  • Strait Access Technologies (Pty) Ltd
  • Suzhou Yinluo Medical Devices Co Ltd
  • Symetis SA
  • Syntach AB
  • Tel Aviv Sourasky Medical Center
  • Tgen Tech LLC
  • The Charles Stark Draper Laboratory Inc
  • Thoratec LLC
  • Thubrikar Aortic Valve, Inc.
  • TransCardiac Therapeutics, LLC
  • Transmural systems LLC
  • TRiCares SAS
  • TTK Healthcare Ltd
  • University College London
  • University of Arizona
  • University of California
  • University of California Irvine
  • University of Cambridge
  • University of Colorado
  • University of Florida
  • University of Manitoba
  • University of Missouri
  • University of Nebraska
  • University of Pennsylvania
  • University of Pittsburgh Medical Center
  • University of South Florida
  • University of Zurich
  • Valcare Medical
  • valsculp
  • Valtech Cardio Ltd
  • ValveXchange, Inc. (Inactive)
  • Vdyne LLC
  • Venus Haoyue Medtech Ltd
  • Venus Medtech Hangzhou Inc
  • Vesalius Cardiovascular Inc
  • Viacor Inc
  • VueKlar Cardiovascular Ltd (Inactive)
  • W. L. Gore & Associates Inc
  • Xeltis AG